Question · asked by 1 review
PIMOZIDE + ANY ANTIPSYCHOTIC vs antipsychotics: Quality of life (change from baseline) in the medium term
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
PIMOZIDE + ANY ANTIPSYCHOTIC vs ANY ANTIPSYCHOTIC Quality of life: average change score medium term (3‐12 months) Specific Level of Functioning, SLOF (high = better, skewed) · patients with schizophrenia or related psychoses Pimozide for schizophrenia or related psychoses (2013) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 53 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pimozide for schizophrenia or related psychoses 2013 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.